Home / Recalls / American Pharmaceutical Ingredients LLC / D-0937-2017

D-0937-2017 Class II Terminated

Recalled by American Pharmaceutical Ingredients LLC — Waterford, MI

Recall Details

Product Type
Drugs
Report Date
July 12, 2017
Initiation Date
May 26, 2017
Termination Date
May 31, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,000g (5 kg)

Product Description

Methocarbamol, USP, packaged in a) 100 g container (NDC: 58597-8023-6, b) 500 g container (NDC: 58597-8023-7), c) 1,000 g container (NDC: 58597-8023-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Reason for Recall

CGMP Deviations: Lack of quality assurance at the API manufacturer.

Distribution Pattern

Nationwide

Code Information

Lots: MCMR1308029NS, MCMR1308029NS-4202015; Exp. 08/18

Other recalls by American Pharmaceutical Ingredients LLC

  • D-0592-2018 Class II — Sermorelin Acetate, powder, a) 1 GM-bottle (NDC58597-8092-1) b) 5 GM-bottle (NDC (March 7, 2018)
  • D-0591-2018 Class II — Oxytocin USP, powder, 1g-bottle, API American Pharmaceutical Ingredients, NDC 58 (March 7, 2018)
  • D-0509-2018 Class II — Liothyronine Sodium USP for prescription compounding ,1g, RX only, packed by Am (February 9, 2018)
  • D-0480-2018 Class II — Clonidine HCl USP for prescription compounding, packaged in a) 5g (NDC 58597-801 (February 9, 2018)
  • D-0533-2018 Class II — Vardenafil HCl USP (trihydrate) for prescription compounding, packaged in a) 5g (February 9, 2018)
  • D-0511-2018 Class II — Naltrexone HCl USP (Dihydrate) for prescription compounding, packaged in a) 1g ( (February 9, 2018)
  • D-0498-2018 Class II — Ketamine HCl USP for prescription compounding, packaged in a) 25g (NDC 58597-833 (February 9, 2018)
  • D-0525-2018 Class II — Testosterone (Soy) (Micronized) USP for prescription compounding, packaged in a) (February 9, 2018)
  • D-0482-2018 Class II — Cyclosporine USP, for prescription compounding, packaged in a) 5g (NDC 58597-821 (February 9, 2018)
  • D-0481-2018 Class II — Cyclobenzaprine HCl USP for prescription compounding, packaged in a) 25g (NDC 58 (February 9, 2018)